Phase II Vanguards
Phase II Vanguards is an interactive data visualization tool providing a comprehensive oversight of the dynamic world of Phase II clinical trials spearheaded by small pharma companies and research innovators.
Explore a wealth of information from geographical distribution, disease focus, drug development progress, to study statuses, and unlock valuable insights into the pioneering forces driving breakthroughs in healthcare.
Explore a wealth of information from geographical distribution, disease focus, drug development progress, to study statuses, and unlock valuable insights into the pioneering forces driving breakthroughs in healthcare.
Number of Investigational New Drugs Investigated by a Vanguard Company
©2023 Cyntegrity — All rights reserved
Number of Active Clinical Trials Run by Vanguard Companies, Categorized by Primary Disease
©2023 Cyntegrity — All rights reserved
Number of Active Clinical Trials Run by Vanguard Companies by Status and Primary Disease
©2023 Cyntegrity — All rights reserved
Geographical distribution of vanguard companies' phase II study sites (2021 - 2023)
©2023 Cyntegrity — All rights reserved
